These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8235347)

  • 61. [Influence of aluminum adjuvant to experimental rabies vaccine].
    Lin H; Perrin P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):133-5. PubMed ID: 12569779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case.
    Marsee DK; Williams JM; Velazquez EF
    Am J Dermatopathol; 2008 Dec; 30(6):622-4. PubMed ID: 19033943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Sequential determination by thermometric titration of Al3+, Ca2+ and Mg2+ in various antacid drugs].
    Boudeville P; Chauvel Y
    Ann Pharm Fr; 1984; 42(2):179-86. PubMed ID: 6486663
    [No Abstract]   [Full Text] [Related]  

  • 64. Inactive pharmaceutical ingredients : implications for pregnancy.
    Finkelstein Y; Rezvani M; Garcia-Bournissen F; Nurmohamed L; Koren G
    Can J Clin Pharmacol; 2007; 14(1):e17-28. PubMed ID: 17213505
    [No Abstract]   [Full Text] [Related]  

  • 65. Tolerance of antacids.
    Sewing KF
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):75-7. PubMed ID: 8260737
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.
    Shaw CA; Tomljenovic L
    Immunol Res; 2013 Jul; 56(2-3):304-16. PubMed ID: 23609067
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Adjuvants and additives in vaccines--medical relevance].
    Wiedermann-Schmidt U; Maurer W
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):510-9. PubMed ID: 16160800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
    Hem SL; Hogenesch H
    Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety evaluation of dietary aluminum.
    Soni MG; White SM; Flamm WG; Burdock GA
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):66-79. PubMed ID: 11259180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Vaccine adjuvants and macrophagic myofasciitis].
    Siegrist CA
    Arch Pediatr; 2005 Jan; 12(1):96-101. PubMed ID: 15653065
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Application of chitin and its derivatives to pharmaceutical industry for traditional Chinese medicine].
    Zhou B; Gao WY; Zhang TJ; Chen HX
    Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1313-6. PubMed ID: 16323536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Aluminum and Alzheimer's disease].
    Belojević G; Jakovljević B
    Srp Arh Celok Lek; 1998; 126(7-8):283-9. PubMed ID: 9863396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review.
    Edris AE
    Phytother Res; 2007 Apr; 21(4):308-23. PubMed ID: 17199238
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Penetration enhancers.
    Williams AC; Barry BW
    Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Therapeutic and toxic properties of pharmaceutical preparations containing Al3+].
    Umbreit MH
    Rocz Panstw Zakl Hig; 1993; 44(1):81. PubMed ID: 8235347
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.